Brief: NanoRepro says is near approval of its HIV test
16/10/2014 13:12
Oct 16 (Reuters) - NanoRepro AG NN6G.DE
* Says has all conditions for approval of so-called "Anhang
II Liste A Produkts" and is near approval of HIV tests by
authorized institution
Source text for Eikon: ID:nEQ7C8TNRa
Further company coverage: NN6G.DE
((Gdynia.newsroom@thomsonreuters.com; Gdynia Newsroom: +48 58
698 39 20;))
Keywords: NANOREPRO AG/BRIEF
Recent news on NanoRepro AG
See all newsBrief: NanoRepro Enters Market For Diabetes Diagnostics
Brief: NanoRepro FY Profit After Taxes At EUR 29.7 Mln
Brief: Nanorepro Announces Talks With Viromed Group On Integration Of Individual Business Units Terminated For The Time Being
Brief: NanoRepro Completes Comparative Study, Says Its Tests Detect Omicron
Brief: NanoRepro - Change In Forecast 2021 And Outlook 2022 With Dividend